- Home
- OCX vs CALC Comparison
OCX vs CALC Comparison
Compare OCX & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- CALC
- Stock Information
- Founded
- OCX 2009
- CALC 2011
- Country
- OCX United States
- CALC United States
- Employees
- OCX N/A
- CALC N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- OCX Health Care
- CALC Health Care
- Exchange
- OCX Nasdaq
- CALC Nasdaq
- Market Cap
- OCX 38.7M
- CALC 40.3M
- IPO Year
- OCX N/A
- CALC N/A
- Fundamental
- Price
- OCX $2.20
- CALC $2.74
- Analyst Decision
- OCX Buy
- CALC Strong Buy
- Analyst Count
- OCX 3
- CALC 5
- Target Price
- OCX $4.42
- CALC $18.20
- AVG Volume (30 Days)
- OCX 112.4K
- CALC 68.7K
- Earning Date
- OCX 11-12-2024
- CALC 11-13-2024
- Dividend Yield
- OCX N/A
- CALC N/A
- EPS Growth
- OCX N/A
- CALC N/A
- EPS
- OCX N/A
- CALC N/A
- Revenue
- OCX $709,000.00
- CALC N/A
- Revenue This Year
- OCX N/A
- CALC N/A
- Revenue Next Year
- OCX $106.34
- CALC N/A
- P/E Ratio
- OCX N/A
- CALC N/A
- Revenue Growth
- OCX N/A
- CALC N/A
- 52 Week Low
- OCX $1.98
- CALC $2.05
- 52 Week High
- OCX $3.82
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- OCX 29.70
- CALC 32.63
- Support Level
- OCX $2.33
- CALC $2.71
- Resistance Level
- OCX $2.48
- CALC $3.27
- Average True Range (ATR)
- OCX 0.16
- CALC 0.26
- MACD
- OCX -0.01
- CALC -0.01
- Stochastic Oscillator
- OCX 39.29
- CALC 47.59
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.